依普利酮在国内可以买到吗？

Can I buy it in China? Currently, eplerenone has not been approved for marketing in China, so patients cannot purchase the drug in domestic pharmacies.

Eplerenone (Inspra) was developed by Pfizer of the United States and was first launched in the United States in 2004. It is suitable for essential hypertension and heart failure after myocardial infarction. For severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs, the addition of eplerenone (Inspra) can significantly reduce blood pressure, especially the decrease in systolic blood pressure is more significant. The combined treatment of eplerenone (Inspra) with angiotensin-converting enzyme inhibitors (ACEI) and receptor blockers can improve patients' quality of life and reduce mortality in severe heart failure and myocardial infarction.

Eplerenone (Inspra) is a new generation of selective aldosterone antagonist. Its outstanding advantage is that for severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs, the addition of eplerenone can significantly reduce blood pressure, especially the decrease in systolic blood pressure is more significant. For patients with severe heart failure and myocardial infarction, eplerenone (Inspra) combined with angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers can improve quality of life and reduce mortality.

Treatment with eplerenone will also produce certain side effects or adverse reactions. The most common side effects include: cough/diarrhea/abdominal pain/angina pectoris/myocardial infarction/proteinuria/headache/vertigo/fatigue/flu-like symptoms, etc.

The above is the introduction about (eplerenone), I hope it can help everyone. If patients have other questions about the drug (such as drug price, purchasing channels, etc.), they can consult the medical companion travel service.

Recommended hot articles: /newsDetail/83222.html